Appointment of Secretarial Auditor, Senior Management Personnel and Chief Risk Officer.
BLACKROSE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved standalone and consolidated unaudited results for Q1 FY26 (quarter ended 30 June 2025). Standalone revenue from operations stood at ₹59.85 crore, down about 19% from ₹74.18 crore in Q1 FY25, while net profit declined roughly 9% to ₹4.24 crore (EPS of ₹0.83 vs ₹0.83). The 35th AGM was scheduled for 29 September 2025 via video conferencing. CFO Ratan Agrawal was given the additional role of Chief Risk Officer, while Dr. Pavankumar Aduri (VP-Innovation) and Mr. Bhavesh Shah (GM-Sales) were designated as Senior Management Personnel, with Bhavesh Shah stepping down from the KMP category. M/s. Shiv Hari Jalan & Co. was appointed as Secretarial Auditor for a 5-year term (FY26–FY30). The board also approved plans for the closure, sale, or transfer of its entire 100% stake in wholly-owned material subsidiary B.R. Chemicals Co. Ltd, Japan, whose operations were already discontinued from 30 January 2025.
Shareholders should note the sharp year-on-year decline in both standalone and consolidated revenues, mainly reflecting the wind-down of the Japan subsidiary which contributed 13.57% of consolidated income last year. The proposed divestment of the Japan arm will streamline the business but removes a notable revenue contributor, while the senior management reshuffle signals a focus on tighter risk oversight.